4//SEC Filing
BRENNAN MURRAY 4
Accession 0001209191-17-062374
CIK 0001107421other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:41 PM ET
Size
8.6 KB
Accession
0001209191-17-062374
Insider Transaction Report
Form 4
BRENNAN MURRAY
Director
Transactions
- Tax Payment
Common Stock
2017-11-20$4.32/sh−12,639$54,600→ 62,175 total - Exercise/Conversion
Common Stock
2017-11-20$2.73/sh+20,000$54,600→ 74,814 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-20−20,000→ 0 totalExercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents shares withheld to pay exercise price.
- [F2]6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001338535
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:41 PM ET
- Size
- 8.6 KB